S&P Futures
4,611.25 -43.50 (-0.93%) Dow Futures
35,585.00 -211.00 (-0.59%) Nasdaq Futures
15,348.75 -247.00 (-1.58%) Russell 2000 Futures
2,138.00 -19.70 (-0.91%) Crude Oil
85.30 +1.48 (+1.77%) Gold
1,813.40 -3.10 (-0.17%)
Beam Therapeutics Inc. (BEAM)
After hours:
Chart Events
Performance Outlook
| Previous Close | 66.13 |
| Open | 65.18 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 800 |
| Day's Range | 63.64 - 68.63 |
| 52 Week Range | 56.34 - 138.52 |
| Volume | |
| Avg. Volume | 621,245 |
| Market Cap | 4.621B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.54 |
| Earnings Date | Mar 14, 2022 - Mar 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 122.89 |
- Zacks
The Zacks Analyst Blog Highlights: Pfizer (PFE), Beam Therapeutics, AbbVie, Merck and Glaxo
Pfizer (PFE), Beam Therapeutics, AbbVie, Merck and Glaxo are highlighted in this analyst blog article.
- Motley Fool
Is Beam Therapeutics a Good Stock to Buy Now?
Beam Therapeutics (NASDAQ: BEAM) recently signed a major research deal with Pfizer (NYSE: PFE) that could be worth up to $1.35 billion, and hardly anyone seemed to notice. Instead of surging higher in response to the Pfizer deal, Beam Therapeutics stock actually fell nearly 2% on the day of the announcement. Over the past few years, Pfizer has watched its peers experiment with CRISPR-based gene editing techniques without making any significant investments.
- Barrons.com
Las Vegas Sands Stock Could See Better Luck Ahead
After 35% plunge in 2021, the gambling stock looks attractive. Also, Wall Street opinions on Domino’s Pizza, Tower Semiconductor, Beam Therapeutics, and Kratos Defense & Security Solutions.
